Código QR (código de barras bidimensional)

The Landscape of Immunotherapy Resistance in NSCLC

Lung cancer is the leading cause of cancer mortality worldwide. Immunotherapy has demonstrated clinically significant benefit for non-small-cell lung cancer, but innate (primary) or acquired resistance remains a challenge. Criteria for a uniform clinical definition of acquired resistance have been r...

תיאור מלא

שמור ב:
Principais autores: Daniele Frisone, Alex Friedlaender, Alfredo Addeo, Petros Tsantoulis
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2022-04-01
סדרה:Frontiers in Oncology
נושאים:
immunotherapy
resistance
checkpoint inhibitor
NSCLC
lung cancer
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/fonc.2022.817548/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים